"58264-0313-1" National Drug Code (NDC)

A-21 29.57 mL in 1 BOTTLE, GLASS (58264-0313-1)
(DNA Labs, Inc.)

NDC Code58264-0313-1
Package Description29.57 mL in 1 BOTTLE, GLASS (58264-0313-1)
Product NDC58264-0313
Product Type NameHUMAN OTC DRUG
Proprietary NameA-21
Non-Proprietary NameAlternaria Alternata, Aspergillus Niger Var. Niger, Cochliobolus Spicifer, Gibberella Fujikuroi, Cochliobolus Sativus, Cladosporium Bruhnei, Mucor Plumbeus, Penicillium Chrysogenum Var. Chrysogenum, Aureobasidium Pullulans Var. Pullutans, And Rhizopus Stolonifer
Dosage FormSOLUTION
UsageSUBLINGUAL
Start Marketing Date19900101
Marketing Category NameUNAPPROVED HOMEOPATHIC
ManufacturerDNA Labs, Inc.
Substance NameALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; CLADOSPORIUM BRUHNEI; COCHLIOBOLUS SATIVUS; COCHLIOBOLUS SPICIFER; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; RHIZOPUS STOLONIFER
Strength30; 30; 30; 30; 30; 30; 30; 30; 30; 30
Strength Unit[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmacy ClassesAllergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/58264-0313-1